Insight

Elizabeth McKenna: Study on Vascular Normalization and Enhanced Immunotherapy

Elizabeth McKenna/X

Jun 3, 2025, 18:18

Elizabeth McKenna: Study on Vascular Normalization and Enhanced Immunotherapy

Elizabeth McKenna, Executive Editor of Cancer Discovery, shared a post on X about a paper by Min Wang et al. published in Cancer Discovery:

“Now online in Cancer Discovery: Vascular Normalization Augments the Anti-tumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors – by Min Wang, Yanxing Chen, Lin Tian, Chenyi Wu, Jiaying Chen, Jiajia Hu, Feng Wang, Rui-Hua Xu, and colleagues”

Title: Vascular Normalization Augments the Anti-tumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors

Journal: Cancer Discovery

Authors: Min Wang, Yanxing Chen, Lin Tian, Chenyi Wu, Jiaying Chen, Jiajia Hu, Runjie Huang, Yingnan Wang, Jinling Zhang, Xiao-Jie Ouyang, Liqin Wang, Ying Jin, Qi Zhao, Feng Wang, Rui-Hua Xu

Read the full article.

Immunotherapy

More posts featuring Elizabeth McKenna on OncoDaily.

AACR cancer Cancer Discovery Chenyi Wu Elizabeth McKenna Feng Wang HDAC Inhibitor immunotherapy Jiajia Hu Jiaying Chen Jinling Zhang Lin Tian Liqin Wang Min Wang OncoDaily Oncology Qi Zhao Rui-Hua Xu Runjie Huang solid tumors Xiao-Jie Ouyang Yanxing Chen Ying Jin Yingnan Wang

Agenus and Zydus Group Announced a $141M Strategic Collaboration to Advance the Manufacturing and Global Development of BOT/BAL

15 Posts Not to Miss from the 4th Day of ASCO 2025

15 Posts Not to Miss from the 3rd Day of ASCO 2025

MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment

15 Posts Not to Miss from the 2nd Day of ASCO 2025